Therapy Area/Business Area
Oncology/New product Planning
The Business Issue
- What will be the impact of launching 2 new cancer drugs?
- What are the business risks we are being exposed to?
The Impact
A fast comprehensive report, enabling greater knowledge of the business impact & risks
The SmartAnalyst Approach
- Produce Scoping document for collaboration with client
- Provide project milestones and key touch-points
- Agree approach, outputs and project price
- Conduct in-depth secondary research to size and evaluate the market
- Identify gaps and undertake additional primary research as applicable (KOL’s/specialists)
The Output (4 week turnaround)
- An Analytical report, detailing in-depth secondary analysis with focused primary research on the size and value of the market
- Provide insights into the product, the indication, its competitors, potential pipeline threats and the clinical trial status
- Indicate the possible impact on the client’s portfolio
Client
Global Private Equity Firm- Commercial Director and their New Product Planning Team
|
|
 |
Pharmaceutical Case Studies:
Business Development
Corporate Development
Commercial Development
New Product Planning
Marketing
Risk Management
Strategic Development
Licensing & Acquisition
Forecasting
Research & Development
Competitive Intelligence
Brand Management
Clinical Development & Regulatory
Information Sciences
Pre-Launch Planning
Post-Launch Planning |
| |
|
|
